U.K.'s MHRA investigating safety of paclitaxel-eluting stents and balloons in PAD treatment March 15, 2019 By Nuala Moran LONDON – The U.K. Medicines and Healthcare products Agency (MHRA) has followed the U.S. FDA's lead and ordered an investigation into the safety of paclitaxel eluting balloons and stents in the treatment of peripheral arterial disease.Read More
Australia to accept conformity assessments from U.K. NBs in no-deal Brexit scenario March 15, 2019 By Tamra Sami
Guardant sees $8B+ valuation only months post-IPO, as it and Natera pop on earnings optimism March 15, 2019 By Stacy Lawrence
RSS